. Comparison of HOMO and LUMO orbital surfaces of H1 and Q4 using DFT B3LYP/6-31G(d) scrf = (cpcm, solvent=dichloromethane) method. E gap = E LUMO -E HOMO Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2017 Figure S1 . Quantum yield Measurements of H1. In order to measure the quantum yield of H1, a reference IR-26 (0.5%) was chosen. 1, 2 Five difference concentrations were measured and the integrated fluorescence was plotted against absorbance for both IR-26 and H1. Comparison of the slopes led to the determination of the quantum yield of H1. The quantum yield was calculated in the following manner: 
Materials and General Experimental Methods.
The 1 H and 13 C NMR spectra were acquired on a Bruker AV400 magnetic resonance spectrometer. Chemical shifts (ppm) were reported relative to internal CDCl 3 ( 1 H, 7.26 ppm and 13 C, 77.0 ppm) and DMSO-d 6 ( 1 H, 2.49 ppm and 13 C, 39.0 ppm). High-resolution mass spectra were performed on Thermo Scientific Q Exactive Focus mass spectrometer. MALDI-TOF-MS experiments were performed on an Applied Biosystems 4700 MALDI TOF mass spectrometer. UV-Vis absorbance of the probe was recorded on a PerkinElmer Lambda 25 UV-Vis spectrophotometer. The NIR-II system was purchased from Suzhou NIR-Optics Technologies CO., Ltd. NIR fluorescence spectrum was recorded on an Applied NanoFluorescence spectrometer at room temperature with an excitation laser source of 785 nm. Hydrodynamic diameter was measured using a Malvern Zetasizer Nano ZS. Transmission electron microscopy (TEM) images were recorded on a Hitachi TEM system at an accelerating voltage of 100 kV. Preparative high performance liquid chromatography (HPLC) was performed on a Dionex HPLC System with UV-Vis detection A reversed-phase C4 (Ultimate, 5 μm, 4.6 × 250 mm) column was used for semi-preparation (mobile phase: water/acetonitrile with 0.06 % TFA). Tetrahydrofuran (THF)was freshly distilled from sodium/benzophenone. N,N-Dimethylformamide (DMF) and dichloromethane(CH 2 Cl 2 )were distilled from calcium hydride. PEG 1000 -NH 2 was purchased from Peng Sheng Biological. All other standard synthesis reagents were purchased from commercial suppliers (such as Aldrich, Energy Chemical) and used without further purification unless otherwise noted. TLC analysis was performed on silica gel plates and column chromatography was conducted over silica gel (mesh 200-300), both of which were obtained from the Qingdao Ocean Chemicals. 
Synthesis and characterization Synthesis of H1

Synthesis of compound 2
This compound was prepared by a modified procedure according to previous reports. 3 To a solution of 4,7-dibromo-5,6-dinitro-benzo [1, 2, 5] thiadiazole (1.92 g, 5 mmol) and 2-thienyl tributylstannane (4.66 g, 12.5 mmol) in freshly distilled THF (35 mL) was bubbled with argon for 10 min. Pd(PPh 3 ) 4 (289 mg, 0.25 mmol) was added to the above reaction mixture under an argon atmosphere. The mixture was heated to reflux and it was stirring overnight. After cooling, saturated aqueous potassium fluoride (40 mL) was added and stirred at room temperature for 1 hour. The reaction mixture was filtered through Celite pad, the filter cake was washed with dichloromethane. The organic layer was washed with saturated aqueous brine, dried over anhydrous magnesium sulfate and the solvent was concentration under reduced pressure. The crude product was recrystallized from ethyl acetate. The desired product 2 (1.8 g, 92% yield) was obtained as an orange powder.
Synthesis of compound 3
This compound was prepared by a modified procedure according to previous reports. 4 5,6-dinitro-4,7-di-thiophen-2-yl-benzo [1, 2, 5] thiadiazole (780 mg, 2 mmol) was dissolved in a mixture of DMF (10 mL) and MeCN (5 mL). The solution was heated to 65°C and N-bromosuccinimide (783 mg, 4.4 mmol) was added in one portion and the reaction stirred in the dark. Then HBr (four drops, 48 weight % aqueous) was added to the reaction. After 3 h, thin layer chromatography analysis revealed three spots. Another portion of N-bromosuccinimide (480 mg, 2.7 mmol) was added and the reaction was allowed to continue for additional 2 h. When a total amount of 1263 mg N-bromosuccinimide (7.1 mmol) had been added, thin layer chromatography analysis indicated the complete conversion of the starting materials. After cooling, the reaction mixture was acidified with hydrochloric acid (180 mL, 2 M) and stirred at room temperature for 2 h. The precipitate was collected by filtration and washed with water and methanol to give the desired compound 3 (986 mg, 90%) as an orange red powder. 
Synthesis of compound 4-3
To a solution of compound 4-2 (4.81 g, 10 mmol) and 2-trimethylsilylethanol (7.75 mL, 54 mmol, 6.39 g) in CH 2 Cl 2 (24 mL) and DMF (36 mL) was cooled at -15 °C under an argon atmosphere. EDCI (9.59 g, 50 mmol) and DMAP (1.96 g, 16 mmol) were added in a single portion and the reaction mixture was stirred at -15 °C for 5 h. The reaction mixture was then allowed to warm at ambient temperature. After dilution with dichloromethane (300 mL), the organic layer was washed with saturated NH 4 Cl solution (200 mL), water (4×200 mL), saturated aqueous brine (100 mL), dried over anhydrous magnesium sulfate, filtered and concentrated to dryness. The residue was crystalized by n-hexane/EtOAc to yield compound 4-3 (4.74 g, 69% 
Synthesis of compound 6
To a solution of compound 5 (70 mg, 0.1 mmol) and compound 3 (27.4 mg, 0.05 mmol) in THF (2.5 mL) was bubbled with argon for 5 min. Potassium carbonate (18 mg, 0.125 mmol) in 0.5 mL distilled water and 1,1'-Bis(diphenylphosphino)ferrocenepalladium(II)dichloride dichloromethane complex (9 mg, 0.01 mmol) were added to the above reaction mixture under an argon atmosphere. The mixture was heated in an oil bath at 75 °C for 14 h. After cooling to room temperature, the solvent was removed in vacuo. The residue was dissolved in dichloromethane, and the resulting solution was washed with water, saturated aqueous brine. After drying over anhydrous magnesium sulfate and removal of the solvents under reduced pressure, product 6 (67 mg, 90% yield) was obtained as a dark red solid which can be used in the next step without further purification. 
Synthesis of compound H1
Zinc dust (392 mg, 6 mmol) and NH 4 Cl (96.3 mg, 1.8 mmol) were added to a stirred solution of compound 6 (72 mg, 0.05 mmol) in dichloromethane (7.2 mL) and 90% methanol (11.4 mL) under an argon atmosphere. After being stirred at room temperature for 4 h, the solution was filtered through Celite pad, diluted with dichloromethane, and washed with water, saturated aqueous NaHCO 3 , and saturated aqueous brine. The organic phase was dried over anhydrous MgSO 4 , filtered and concentrated under vacuum to afford a yellow solid which was utilized for the next step without further purification. To a dark yellow solution in anhydrous pyridine (1 mL) was added N-thionylaniline (0.2 mL, 1.8 mmol, 247 mg) and chlorotrimethylsilane (0.3 mL, 3.5 mmol, 377 mg). The mixture was heated in an oil bath at 80°C for 20 h. The reaction mixture was allowed to cool down to room temperature, poured into iced water, extracted with dichloromethane. The combined organic layer was washed with water, saturated aqueous brine, dried over anhydrous MgSO 4 , and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (10:1 petroleum ether: ethyl acetate to 100 :1 dichloromethane : methanol) to yield the product H1 as a light dark yellow solid (34 mg, two step 48% yield). To a solution of compound H1 (34 mg, 0.024 mmol) in DCM (3 mL) was cooled at 0 °C. Trifluoroacetic acid (3 mL) was added and the reaction mixture was stirred at 0 °C for 3 hours. The reaction mixture was slowly warmed to ambient temperature. The solvent was removed in vacuo and the crude product was washed by dichloromethane to yield the desired compound 7 as a dark solid which was used for the next step without further purification. 
MALDI-TOF-MS
Synthesis of SXH
To a solution of compound 7 (2 mg, 0.002 mmol) and NH 2 -PEG (32 mg, 0.032 mmol, M.W. ~1000) in anhydrous DMF (1 mL) was added HBTU (15 mg, 0.04 mmol) and DIPEA (20 µL) at room temperature under an argon atmosphere. The reaction mixture was stirred at room temperature for 24 h. The crude product was precipitated in cold diethyl ether. The crude product was dissolved in water and purified by HPLC. Lyophilization of the purified material gave the desired product (3.2 mg, 33%) as a dark yellow solid. The final product SXH was confirmed using MALDI-TOF-MS. Expected M.W. ~4930, Measured M.W. ~4921.
Synthesis of SDH
To a solution of compound 7 (4 mg, 0.004 mmol) and c(RGDfK) (2.4 mg, 0.004 mmol) in anhydrous DMF (1 mL) was added HBTU (3 mg, 0.008 mmol) and DIPEA (10 µL) at room temperature under an argon atmosphere. The reaction mixture was stirred at room temperature for 24 h. 
Synthesis of H1 NPs
The H1 was dissolved in THF at a concentration of 0.1 mg/mL and mixed with an aqueous solution of DSPE-mPEG (5 kDa) at a concentration of 1 mg/mL with 1 : 9 volume ratio was stirred at room temperature for 2 h. After THF was removed by nitrogen flow, this reaction mixture was centrifuged at 12,000 rpm for 3 min using 30 kDa molecular weight cut-off filter to remove unreacted reagents, and washed by water 6 times using the same filter. The complex was finally re-dissolved in 0.5 mL water, followed by ultracentrifugation (50,000 rpm for 30 min). Supernatant was thus acquired as the solution of H1NPs. The amount of H1 encapsulated in the liposomes was measured by UV/VIS spectrophotometer at 874 nm. The calibration curve was linear in the range of 2.5-40 µg/mL with a correlation coefficient of R 2 = 0.99918.
The encapsulation efficiency was defined as the ratio between the amount of H1encapsulated in the liposomes and that added in the liposomes preparation process. The dye encapsulation efficiency of H1 NPs was 79.8%±0.6%( n = 3).
Figure S10. The calibration curve of H1 NPs
Cell line and animal model. Human primary glioblastoma cell line U87MG and mouse fibroblastic cell line L929 were obtained from the American Type Culture Collection (ATCC). U87MG Cells were cultured in Low Glucose Dulbecco's Modified Eagle Medium (DMEM) medium (Gibco) supplemented with 10% fetal bovine serum, 100 IU/mL penicillin, 100 µg/mL streptomycin. L929 cells were cultured in Mimumum Essentiul Medium (MEM) medium (Gibco) supplemented with 10% fetal bovine serum, 100 IU/mL penicillin, 100 µg/mL streptomycin. All cells were cultured at 37 °C in a humidified with 5% CO 2 atmosphere. The U87MG rat tumor model was established by subcutaneous injection of U87MG cells (roughly 2 × 10 6 in 50 μL of Low Glucose DMEM medium) into the right leg of the 6-week-old female Balb/c nude mice (Suzhou Belda Bio-Pharmaceutical Co.). The tumor was allowed to reach ~5-10 mm in diameter (about 2 weeks after inoculation) and the mice were subjected to imaging studies. All animal experiments were performed according to the Chinese Regulations for the Administration of Affairs Concerning Experimental Animals.
Cell cytotoxicity in MTT assay.
In vitro cytotoxicity studies of SXH or SDH or H1 NPs on L929 cells and U87MG cells were performed by using a MTT cytotoxicity assay. Cells were cultured overnight in 96-well plates at 5×10 3 cells per well to allow cell attachment. The cells were incubated with 100 μL of fresh cell media containing of SXH or SDH or H1 NPs for 48 h. The final concentrations of SXH or SDH or H1 NPs in the culture medium were fixed at 0, 1, 2, 4, and 8 μM in the experiment. Then the MTT (0.5 mg/mL) reagent (10 μL per well) was added for 4 h at 37 °C and DMSO (150 µL per well) was further incubated with cells to dissolve the precipitated formazan violet crystals at 37 °C for 15 min. The absorbance was measured at 490 nm by Perkin Elmer VICTOR X4. The following formula was used to calculate the viability of cell growth: Cell viability (%) = (mean of Absorbance value of treatment group /mean of Absorbance value of control) × 100.
In vivo NIR-II fluorescence imaging of tumors.
A 200 μL portion of SXH or SDH or H1 NPs at a 0.5 mg/mL concentration was injected intravenously into nude mice. During injection and imaging, the mice were anesthesized using a 2 L/min oxygen flow with 2% Isoflurane. NIR-II fluorescence images were collected using a two-dimensional InGaAs array (Suzhou Optics) for collecting photons in NIR-II. The excitation light was provided by an 808 nm diode laser. The emitted light from the animal was filtered through a 1000 nm long-pass filter coupled with the InGaAs camera for NIR-II imaging. The exposure time for all images was 200 ms.
Ex vivo biodistribution analysis.
Ex vivo fluorescence imaging of organs and tissues, was performed with a home-built NIR-II fluorescence imaging system with an InGaAs camera under illumination of an 808 nm laser diode at a power density of roughly 50 mW/cm 2 and an exposure time of 200 ms. 72 h after injection of SDH or 24 h after injection of SXH, U87MG mice (n = 3 per group) were sacrificed, the major organs and tissues were collected. Then the NIR-II fluorescent signal of each subject was collected.
Determination of the fluorescence quantum yield.
The fluorescence quantum yield measurement was carried out using IR-26 whose quantum yield has been reported as 0.5% in 1,2-dichloroethane (DCE) as reference. In a typical procedure, a series of solutions of IR-26 in DCE with absorbance values at 785 nm to be ~ 0.10, ~ 0.08, ~ 0.06, ~0.04 and ~0.02 were prepared respectively. Optical absorbance spectra of the five solutions were measured using PerkinElmer Lambda 25 UV-Vis spectrophotometer. NIR emission spectra of the five solutions with linearly spaced concentrations were measured using Applied NanoFluorescence spectrometer. The 785 nm laser was used as the excitation source and a 900 nm longpass filter was used as the emission filter to acquire the emission spectrum in the range of 900 to 1600 nm. Same solution preparation, absorbance and fluorescence spectra measurements were performed for H1. 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180 f1 (ppm) 
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